Form 4: Alpha Tau Medical CFO Sells Shares

Alpha Tau Medical Ltd. CFO Raphi Levy reported a sale of 20,000 ordinary shares on June 25, 2026, for a total transaction value of $220,000.

Summary

• Raphi Levy, Chief Financial Officer of Alpha Tau Medical Ltd., reported a transaction on June 25, 2026.
• The transaction involved the sale of 20,000 ordinary shares.
• The sale was executed at a price of $11.00 per share.
• The total value of the transaction was $220,000.
• Following the transaction, Mr. Levy beneficially owns 110,180 ordinary shares directly.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a slightly negative filing due to the CFO's sale of shares, which can be interpreted as a bearish signal, although the price point and quantity require further analysis in the context of the individual's holdings and compensation.

Negatives

• The Chief Financial Officer sold a significant number of shares, which could be perceived negatively by the market.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that insider selling, particularly by a CFO, can sometimes signal a lack of confidence in the company's near-term prospects or a need for personal liquidity. However, without further context, it's difficult to ascertain the specific motivation behind this transaction.

Stakeholder Impact

• Shareholders may view the CFO's sale of shares negatively, potentially leading to short-term price pressure.
• Employees with stock options or grants may be concerned about the perceived confidence of senior management.

Key Dates

Recommendation

The filing reports an insider sale by the CFO. While this can be a negative signal, it is a Form 4 filing which typically reports routine transactions. Without additional negative information or context regarding the reason for the sale, a 'hold' recommendation is prudent, suggesting investors monitor further developments rather than making immediate decisions based solely on this transaction.

Keywords

Alpha Tau Medical, DRTS, Form 4, Insider Trading, Share Sale, Raphi Levy, Chief Financial Officer